Journal of Clinical Gastroenterology 2003: Vol 37 Index

9 Pages·2003·2.2 MB·English

JOURNAL OF CLINICAL GASTROENTEROLOGY
Author Index
A Corinaldesi R, 92 GreubG , 129 Kitagawa M, 48
Corless CL, 344 Grigoriadis K, 88 Klaenhammer TR, 105
AbbasogluO , 186
Csuka ME, 125 Guyarro C, 89 Knox JF, 125
AbuksisG , 142 Cuomo R, 392 Giiliter S, 288 Kobayakawa N, 194
Agrawal S, 307
Czaja AJ, 315 Gumaste VV, 119 Kobayashi S, 195
Ahmed A, 68, 349
Giimiirdiilii Yiiksel, 2 Kohout P, 192
Ahmed AM, 68, 349
Aki H, 87 D Giindogdu C, 177 Konturek PC, 34
Gursoy S, 402 Konturek SJ, 34
AAllpm oMgN ,Y , 323700 Daniele B, 281 Guven K, 402 Korelitz BI, 220
Danis R, 330 Koren R, 142
Altarescu G, 234 De Francesco V, 392 H Kori M, 39
Anagnostopoulos GK, 88
De Ninno M, 189 Koruk M, 177
Angulo P, 183, 267 DeCarli LM, 336 Hallevy C, 270 Kostopoulos P, 88
Aoyagi T, 194 Degertekin H, 330 Hardee JT, 271 Kouzu T, 151
Armstrong D, 132 Harms HK, 55
DeMeester TR, 14 Kowdley KV, 278, 406
AArsvaaknai tiMd,i s 35D0, 88 DDiiaalse r L1,M ,5 51 93 HHaarsuemgaa waK , S3, 811 95 Kumazawa K, 412
Asakura T, 173 Dinis-Ribeiro M, 193 Hassan C, 164 L
Ashman QO, 42 Dobrzanska M, 34 Hatanaka K, 350
\tassi Tamer, 78 Dogan I, 292 Heathcote EJ, 395 Lantsberg L, 270
Aydin M, 230 Dranoff JA, 352 Hekimoglu B, 292 Larson AM, 406
Duefio MI, 372 Hige S, 350 Lee RP, 95
B Duerr RH, 358 Hinder RA, 201 Lee SK, 238
Bae J-S, 238 Dvorak J, 192 Hirokawa K, 48 Lee S-S, 238
Bank S, 263 Hiromitsu S, 151 Leis S, 42
Baron T, 368 Hishikawa E, 151 Leo MA, 336
Baskol G, 402 Hiyama T, 381 Lewis M, 1, 275
Baskol M, 402 Eagan RK, 82 Ho Y-P, 251 Liangpunsakul S, 340
Bauermeister D, 406 EickhoffA , 74 Hundt C, 55 Liaudet L, 129
El-Serag HB, 271 Hung PD, 203 Lieber CS, 336
Beer-Gabel M, 39
Behr C, 226 Elstein D, 234 Hunter JG, 280 Lien J-M, 251
Ben-Ari Z, 64 Emmons J, 125 Huszar M, 39 Lindor K, 267
Benifla M, 169 Endo S, 412 Lindor KD, 183
Benz CA, 74 Ensari A, 292 Liu N-J, 251
Berger J, 278 laffaioli RV, 281 Losanoff JE, 194
Bertele-Harms R-M, 55 lerardi E, 392 M
Bettschart V, 129 Faber SM, 93 linuma K, 173
Bielanski W, 34 Fallone CA, 6 Ilan Y, 139 Mantry P, 61
Bilbao J, 89 Fang J-T, 251 Indaram A, 263 Margantinis G, 88
Bilimoria KY, 82 Farmer JW, 147 Israeli E, 139 Martinez-Souss J, 372
Bilir M, 79 Feller E, 258 Ito M, 381 Matsutani S, 151
Binion DG, 125 Matta E, 372
Bobrzynski A, 34 Fernandez C, 89 J Meir SB, 139
Fleisher MR, 220
Borody TJ, 42 Melichar B, 192
Boyacioglu S, 230 Janardhanam R, 220 Melicharova K, 192
Brandimarte G, 387 Fontana RJ, 9 Jao YTFN, 91 Melzer E, 64
Freeman HJ, 216, 299
Breth GF, 271 Jones JW, 194 Mercenier A, 105
Brown A, 100 Fukushima K, 194 Joo Y-E, 28 Mert A, 79, 87
Buchman AL, 303, 312 Jorgensen R, 183 Mesquita N, 193
Budak T, 330 G Misuta K, 195
Buenavida C, 139 Gabrielli M, 189 K Mo L-R, 91
“ GGaarrcciiaa -GC,a n6o8 J, 348 KKaammaignastkaa SA,, 13743 MMoorrii niR , S,1 9156 4
Cao Q, 336 Garcia-Casasola G, 89 Karakan T, 288 Munakata M, 173
Castell DO, 3, 206 Gardner A, 258 Karakok M, 177 Muscatiello N, 392
Celik AD, 79, 87 Gardner G, 258 Kato H, 412 Mustafa M, 307
Chalasani N, 340 Gasbarrini A, 189 Kato S, 173 N
Chan SB, 147 Gasbarrini G, 189 Katsube T, 412
Chayama K, 381 Gaskins HR, 105 Kaur U, 86 Nacher J, 89
Chen P-C, 251 Gemici C, 86 Kayaselcuk F, 230 Nagaoka S, 48
Chen Y-C, 251 Gentile M, 392 KC S, 151 Nagata S, 381
Cherbut C, 105 Gibson GR, 105 Keeffe EB, 68, 349 Nain CK, 86
Chetty R, 23 Giorgetti GM, 387 Kim HJ, 238 Nakanishi M, 350
Chhabra M, 86 Gladish V, 39 Kim M-H, 238 Nakano A, 195
Chinea B, 372 Goel RC, 86 Kim S-J, 28 Naritaka Y, 412
Chiu C-T, 251 Goldin E, 139 Kim Y-J, 28 Nestola M, 189
Chiu H-H, 91 Gopal DV, 344 Kisacik B, 87 Nguyen MH, 68
Choi S-K, 28 Gortzak Y, 270 Kitadai Y, 381 NikaidoT , 151
418 ] Clin Gastroenterol ¢ Volume 37, Number 5, November/December 2003
JOURNAL OF CLINICAL GASTROENTEROLOGY
Author Index
A Corinaldesi R, 92 GreubG , 129 Kitagawa M, 48
Corless CL, 344 Grigoriadis K, 88 Klaenhammer TR, 105
AbbasogluO , 186
Csuka ME, 125 Guyarro C, 89 Knox JF, 125
AbuksisG , 142 Cuomo R, 392 Giiliter S, 288 Kobayakawa N, 194
Agrawal S, 307
Czaja AJ, 315 Gumaste VV, 119 Kobayashi S, 195
Ahmed A, 68, 349
Giimiirdiilii Yiiksel, 2 Kohout P, 192
Ahmed AM, 68, 349
Aki H, 87 D Giindogdu C, 177 Konturek PC, 34
Gursoy S, 402 Konturek SJ, 34
AAllpm oMgN ,Y , 323700 Daniele B, 281 Guven K, 402 Korelitz BI, 220
Danis R, 330 Koren R, 142
Altarescu G, 234 De Francesco V, 392 H Kori M, 39
Anagnostopoulos GK, 88
De Ninno M, 189 Koruk M, 177
Angulo P, 183, 267 DeCarli LM, 336 Hallevy C, 270 Kostopoulos P, 88
Aoyagi T, 194 Degertekin H, 330 Hardee JT, 271 Kouzu T, 151
Armstrong D, 132 Harms HK, 55
DeMeester TR, 14 Kowdley KV, 278, 406
AArsvaaknai tiMd,i s 35D0, 88 DDiiaalse r L1,M ,5 51 93 HHaarsuemgaa waK , S3, 811 95 Kumazawa K, 412
Asakura T, 173 Dinis-Ribeiro M, 193 Hassan C, 164 L
Ashman QO, 42 Dobrzanska M, 34 Hatanaka K, 350
\tassi Tamer, 78 Dogan I, 292 Heathcote EJ, 395 Lantsberg L, 270
Aydin M, 230 Dranoff JA, 352 Hekimoglu B, 292 Larson AM, 406
Duefio MI, 372 Hige S, 350 Lee RP, 95
B Duerr RH, 358 Hinder RA, 201 Lee SK, 238
Bae J-S, 238 Dvorak J, 192 Hirokawa K, 48 Lee S-S, 238
Bank S, 263 Hiromitsu S, 151 Leis S, 42
Baron T, 368 Hishikawa E, 151 Leo MA, 336
Baskol G, 402 Hiyama T, 381 Lewis M, 1, 275
Baskol M, 402 Eagan RK, 82 Ho Y-P, 251 Liangpunsakul S, 340
Bauermeister D, 406 EickhoffA , 74 Hundt C, 55 Liaudet L, 129
El-Serag HB, 271 Hung PD, 203 Lieber CS, 336
Beer-Gabel M, 39
Behr C, 226 Elstein D, 234 Hunter JG, 280 Lien J-M, 251
Ben-Ari Z, 64 Emmons J, 125 Huszar M, 39 Lindor K, 267
Benifla M, 169 Endo S, 412 Lindor KD, 183
Benz CA, 74 Ensari A, 292 Liu N-J, 251
Berger J, 278 laffaioli RV, 281 Losanoff JE, 194
Bertele-Harms R-M, 55 lerardi E, 392 M
Bettschart V, 129 Faber SM, 93 linuma K, 173
Bielanski W, 34 Fallone CA, 6 Ilan Y, 139 Mantry P, 61
Bilbao J, 89 Fang J-T, 251 Indaram A, 263 Margantinis G, 88
Bilimoria KY, 82 Farmer JW, 147 Israeli E, 139 Martinez-Souss J, 372
Bilir M, 79 Feller E, 258 Ito M, 381 Matsutani S, 151
Binion DG, 125 Matta E, 372
Bobrzynski A, 34 Fernandez C, 89 J Meir SB, 139
Fleisher MR, 220
Borody TJ, 42 Melichar B, 192
Boyacioglu S, 230 Janardhanam R, 220 Melicharova K, 192
Brandimarte G, 387 Fontana RJ, 9 Jao YTFN, 91 Melzer E, 64
Freeman HJ, 216, 299
Breth GF, 271 Jones JW, 194 Mercenier A, 105
Brown A, 100 Fukushima K, 194 Joo Y-E, 28 Mert A, 79, 87
Buchman AL, 303, 312 Jorgensen R, 183 Mesquita N, 193
Budak T, 330 G Misuta K, 195
Buenavida C, 139 Gabrielli M, 189 K Mo L-R, 91
“ GGaarrcciiaa -GC,a n6o8 J, 348 KKaammaignastkaa SA,, 13743 MMoorrii niR , S,1 9156 4
Cao Q, 336 Garcia-Casasola G, 89 Karakan T, 288 Munakata M, 173
Castell DO, 3, 206 Gardner A, 258 Karakok M, 177 Muscatiello N, 392
Celik AD, 79, 87 Gardner G, 258 Kato H, 412 Mustafa M, 307
Chalasani N, 340 Gasbarrini A, 189 Kato S, 173 N
Chan SB, 147 Gasbarrini G, 189 Katsube T, 412
Chayama K, 381 Gaskins HR, 105 Kaur U, 86 Nacher J, 89
Chen P-C, 251 Gemici C, 86 Kayaselcuk F, 230 Nagaoka S, 48
Chen Y-C, 251 Gentile M, 392 KC S, 151 Nagata S, 381
Cherbut C, 105 Gibson GR, 105 Keeffe EB, 68, 349 Nain CK, 86
Chetty R, 23 Giorgetti GM, 387 Kim HJ, 238 Nakanishi M, 350
Chhabra M, 86 Gladish V, 39 Kim M-H, 238 Nakano A, 195
Chinea B, 372 Goel RC, 86 Kim S-J, 28 Naritaka Y, 412
Chiu C-T, 251 Goldin E, 139 Kim Y-J, 28 Nestola M, 189
Chiu H-H, 91 Gopal DV, 344 Kisacik B, 87 Nguyen MH, 68
Choi S-K, 28 Gortzak Y, 270 Kitadai Y, 381 NikaidoT , 151
418 ] Clin Gastroenterol ¢ Volume 37, Number 5, November/December 2003
] Clin Gastroenterol ¢ Volume 37, Number 5, November/December 2003
Nio M, 173 Ramsey-Goldman R, 312 Shiraishi J, 48 Tiiziin D, 292
Nista EC, 189 Rapaccini G, 189 Siegel JL, 183 Tiiziin M, 292
Niv Y, 142 Rastall R, 105 Silva RA, 193
Norman GL, 315 Reid G, 105 Simpson ND, 68, 349
Nursal TZ, 186 Reifen R, 39 Simpson PW, 68, 349 U
Reinus C, 234 Singh K, 86 Utsuyama M, 48
O Ren C, 336 Singh P, 263 Uygur-Bayramigli O, 86
Rew J-S, 28 Singh V, 86 Uygur—Bayramicli O, 399
Odes HS, 270
Rex DK, 82 Slivka A, 102
Ogawa K, 412 Rhew EY, 312 Solichova D, 192
Ohi R, 173 V
Ricchi P, 281 Songiir N, 292
Ohnishi S, 350
Richman BW, 194 Songiir Y, 292 Vaiphei K, 86
Ohta M, 195 Riemann JF, 74 Sperber AD, 270 Vega W, 372
Ojeda A, 372 Roberfroid M, 105 Stanghellini V, 92 Vela MF, 206
Oka S, 381 Romero RV, 96 Sterling RK, 203 Viana HL, 193
Olyaei AJ, 344
Rosen HR, 344 Stoppino V, 392
Orbay E, 399
Rosenmann E, 234 Streets CG, 14
Orefice R, 189
Rosoff L, 406 Sundaram U, 61
Otani Y, 194
Rowland I, 105 Surace R, 42 Wallin A, 303
Ozaras R, 79, 87
Suryaprasad S, 307 Walther Z, 4
Ozawa K, 173
Wang V, 155
Ozbakir O, 402
Warman JI, 220
Ozer B, 230
Saab S, 155 Warren EF, 42
Ozturk R, 79, 87 Sachar DB, 99 T Weizman Z, 169
Saeian K, 125 Wiesel P, 129
P Sanders ME, 105 Tabak F, 79, 87 Willson RA, 202
Panella C, 392 Santarelli L, 189 Takemura T, 48 Winiarski M, 34
Pare P, 132 Sargin H, 399 Takeuchi H, 194
Park C-S, 28 Sargin M, 399 Takizawa Y, 350 Y
Parkar JA, 349 Savas MC, 177 Takubo K, 48
Paz J, 234 Sawabe M, 48 Tanaka S, 381 Yalcin K, 330
Pericak D, 132 Sawaki D, 194 Taro A, 151 Yapar AF, 230
Phillips JR, 267 Schaller M-D, 129 Taylor SL, 406 Yayla A, 399
Pignata S, 281 Schilling D, 74 Taysi S, 177 Yilmaz A, 177
Pitt HA, 356 Schmilovitz-Weiss H, 64 Tekes S, 330 Yilmaz MH, 79
Plonka M, 34 Schdnleben K, 226 Thakore JN, 307 Yilmaz O, 177
Pochron N, 368 Sedlack R, 368 Thatcher P, 196 Yilmaz S, 288
Pola P, 189 Seelig MH, 226 Thuluvath PJ, 72 Yilmaz U, 230
Pollack MJ, 272 Seelig SK, 226 Tonti P, 392 Yoshihara M, 381
Ponsky JL, 355 Seki S, 48 Toro DH, 372 Yucesoy M, 402
Pooran N, 263 Sekita G, 194 Torres M, 372
Prajapati DN, 125 Seo DW, 238 Tosetti C, 92 Z
Pyzyk M, 132 Seo Y-H, 28 Tsai M-H, 251
Serin E, 230 Tsiakos S, 88 Zadak Z, 192
R Serricchio M, 189 Tsuchiya A, 412 Zapatero A, 89
Shah A, 61 Tur-Kaspa R, 64 Zimran A, 234
Rabkin JM, 344 Shay SS, 206 Tursi A, 387 Ziv-Sokolovskaya N, 39
Ramasamy K, 119 Shiozawa S, 412 Tutuian R, 206 Zullo A, 164
Subject Index
A Alcoholic liver disease, silymarin in (editorial), Animal model, for silymarin effect in
alcohol-induced hepatic fibrosis, 336
Abdominal examination, for razor blade 278 ; ,
ingestion (letter), 194 Alkalis, ingestion of, 119 Announcements, 97, 199
Abdominal surgery, laparoscopic techniques in Allergic reactions, to treatment of Crohn’s Anti-endomysium antibodies, in assessing
(editorial), 201 disease and ulcerative colitis, 220 histologic recovery after gluten-free diet in,
Abscess, hepatic Alpha-adrenergic receptor antagonist, for 387
colonoscopic identification of foreign body pheochromocytoma complicated with Antimitochondrial antibodies, in liver disease
in, 82 refractory paralytic ileus (letter), 194 diagnosis and management, 315
Fusobacterium necrophorum in (letter), 196 Ambulatory pH monitoring, 24-hour, 14 Antinuclear antibodies, in liver disease diagnosis
Acids, ingestion of, 119 Ammonia, in hepatic encephalopathy, 164 and management, 315
Adenoma, colorectal Amyloidosis, with Gaucher disease, 234 Antireflux procedures, for GERD associated with
cyclo-oxygenase inhibition in, 281 Anemia paraesophageal hiatal hernia, 129
in liver transplant recipients, 72 in malignant tumors of small intestine, 372 Anti-transglutaminase antibodies, in assessing
Aging, in poor prognosis of colorectal cancer, 48 secondary to hemorrhagic solitary rectal ulcer histologic recovery after gluten-free diet, 387
Alcohol intake syndrome, 392 Antiviral therapy, for recurrent hepatitis C after
gastric bicarbonate and (letter), 86 Angiogenesis liver transplant, 155
in hepatic fibrosis, silymarin retarding in gastric cancer, 28 Anular pancreas, in idiopathic acute pancreatitis,
progression of, 336 in gastric cancer (editorial), 4 238
© 2003 Lippincott Williams & Wilkins 419
| Clin Gastroenterol ¢ Volume 37, Number 5, November/December 2003
APACHE system, in predicting outcome of in diagnosing upper gastrointestinal bleeding, predicting outcome of in ICU patients
cirrhosis in critically ill patients (editorial), 34 (editorial), 203
203 in Helicobacter pylori eradication, 142 silymarin retarding progression of, 336
Apolipoproteins, in nonalcoholic steatohepatitis, 177 Cancer treatment considerations of hepatitis C with,
Argon plasma coagulation, of hemorrhagic colorectal 395
solitary rectal ulcer syndrome, 392 cyclo-oxygenase inhibition in, 281 Clinical trials
Ascites, culture negative neutrocytic, ceftriaxone intestinal permeability with raltitrexed for Crohn’s disease (editorial), 99
for, 403 and irinotecan treatment of (letter), of probiotics and prebiotics, 105
Asthma, detection of in inflammatory bowel 192 Clinicopathology, of nonampullary duodenal
disease, 292 duodenal, endoscopic or surgical resection carcinoma, 381
Autoantibodies, in liver disease diagnosis and for (editorial), 356 Cocaine, whole body irrigation for smuggling of,
management, 315 of head and neck 147
Autoimmune hepatitis, hepatocellular carcinoma percutaneous endoscopic gastrostomy in Colitis, genetics of, 358
with (letter), 271 metastasis of, 307 Colon
Autoimmunity tumor implantation at PEG exit sites in inflammation of with pancreatic disease, 258
in liver disease, 315 (editorial), 280 obstruction of, with pancreatic disease, 258
with orthotopic liver transplantation, 344 p27 protein in, 23 Colonoscopy
in recurrent hepatitis, 267 probiotics and prebiotics for, 105 in colorectal adenoma risk screening, 72
Azathioprine, leflunomide for patients intolerant Carcinogenesis for foreign body-related hepatic abscess, 82
Colorectal adenoma, in liver transplant
to, 125 COX-2 and angiogenesis in (editorial), 4
recipients, 72
multistep, in colorectal adenomas and cancer,
Colorectal cancer
B 281
cyclo-oxygenase inhibition in, 281
B-cell lymphoma, free perforation due to, 299 Carcinoma intestinal permeability with raltitrexed and
B,, vitamin, in gastric emptying time, 230 hepatocellular irinotecan treatment of (letter), 192
Baboons, retarding alcohol-induced hepatic with autoimmune hepatitis (letter), 271 poor prognosis of in elderly patients, 48
fibrosis progression in, 336 in nonalcoholic steatohepatitis (letter), 88 Complications, of percutaneous gastrostomy
Bacteriotherapy, for ulcerative colitis, 42 nonampullary duodenal, clinicopathologic (editorial), 355
Benign bile duct strictures, endoscopic stenting features and endoscopic resection of, 381 Computed tomography, high-resolution, for
for, 74 pancreatic, colonic complications of, 258 pulmonary involvement in inflammatory
Bicarbonate, gastric, chronic alcohol intake and Case reports bowel disease, 292
(letter), 86 of recurrent idiopathic hepatitis, 267 Constrictive bronchiolitis, detection of in
Biliary cirrhosis, ursodeoxycholic acid in weight of relapsing hepatitis episodes (editorial), 202 inflammatory bowel disease, 292
gain with, 183 Ceftriaxone, for culture negative neutrocytic Contraband, whole body irrigation for, 147
Biliary strictures, postoperative, endoscopic ascites in cirrhosis, 403 Corrosive ingestion, in adults, 119
stenting for, 74 Celecoxib, in esophagitis, 61 Crohn’s disease
Blunt trauma, in pediatric acute pancreatitis Celiac disease detection of pulmonary involvement in, 292
(editorial), 100 assessing histologic recovery after genetics of, 358
Book reviews gluten-free diet in, 387 leflunomide for, 125
{cute gastrointestinal bleeding: diagnosis intestinal lymphoma in, free perforation due leflunomide for (editorial), 99
and treatment, 352 to, 299 natural history and clinical behavior of, 216
Gastrointestinal disease: an endoscopic Cell cycle proteins, in gastrointestinal and liver short- and long-term toxicity of
approach, 2nd edition, 95 cancers, 23 6-mercaptopurine in treatment of, 220
Gastrointestinal polyps, Ist edition, 96 Cellular immune response, probiotics and Sjogren’s syndrome with, 312
Gastrointestinal radiology, a pattern prebiotics in, 105 treatment of, |
approach, 4th edition, 95 Chemoembolization, transcatheter arterial, for Cumulative toxicity, in treatment of Crohn’s
Hepatobiliary medicine, Q&A color review, hepatocellular carcinoma, 412 disease and ulcerative colitis, 220
353 Chemoprevention, in colorectal adenomas and Cyclooxygenase-2 (COX-2)
cancer, 281
Molecular biology and immunology in in gastric cancer (editorial), 4
Chemotherapy, prophylaxis against hepatitis B
hepatology, 352 overexpression of, vascular endothelial
Virus reactivated by, 68
PDxMD gastroenterology, 352 growth factor expression and tumor
Probiotics and prebiotics, where are we Children angiogenesis and, 28
acute pancreatitis in, 169
going?, 95 Cyclooxygenase-2 (COX-2) inhibitors
Bowel obstruction, transanal decompression tube acute pancreatitis in (editorial), 100 in colorectal adenomas and cancer, 281
for (letter), 195 ERCP scopes for (editorial), 102 gastrointestinal side effects of, 61
Bowel wall thickness, in cystic fibrosis, 55 routine duodenal biopsy in upper intestinal Cyclooxygenase (COX) inhibition, in colorectal
Breath test endoscopy of, 39 adenomas and cancer, 281
for Helicobacter pylori diagnosis, novel small-caliber videoduodenoscope for, 173 Cystic fibrosis, sonographic evaluation of bowel
device for, 139 Cholangiopancreatography, small-caliber wall thickness in, 55
in Helicobacter pylori eradication, 142 videoduodenoscope for in children, 173 Cytokines, in severe acute pancreatitis, 263
Bronchiectasis, detection of in inflammatory Cholecystitis, acute viral, due to hepatitis A
bowel disease, 292 ; virus, 79
D
Bronchoaspiration, with GERD-associated Choledochocele, in idiopathic acute pancreatitis,
paraesophageal hiatal hernia, 129 238 Dermatitis herpetiformis, in celiac disease, 299
Chromatin antibodies, in liver disease diagnosis, Desmoid tumor, sporadic hereditary pancreatic,
C 315 186
Cirrhosis Diabetes mellitus
ye
C-urea breath test ceftriaxone for culture negative neutrocytic non-insulin-dependent, evaluation of
device for in Helicobacter pylori infection ascites in, 403 gallbladder volume and motility in, 288
diagnosis, 139 predicting hospital mortality with, 251 in nonalcoholic fatty liver disease, 399
420
© 2003 Lippincott Williams & Wilkins
] Clin Gastroenterol « Volume 37, Number 5, November/December 2003
with treatment of Crohn’s disease and indications for in children, 39 non-insulin-dependent diabetes mellitus,
ulcerative colitis, 220 in management of bleeding from colonic 288
Diagnostic algorithm, for GERD, 206 Dieulafoy-like lesion (letter), 91 Gallstones, in idiopathic acute pancreatitis, 238
Diagnostic techniques, for liver disease, 315 in stenting for postoperative biliary strictures Gastric bicarbonate, chronic alcohol intake and
Dieulafoy-like lesions, endoscopic management due to hepatic hydatid disease, 74 (letter), 86
of bleeding from (letter), 91 upper intestinal, routine duodenal biopsy in, Gastric bleeding, with Gaucher disease, 234
Disease behavior, of Crohn’s disease, 216 39 Gastric cancer
Disease site, in Crohn’s disease, 216 videocapsule, for obscure gastrointestinal COX-2 and angiogenesis in (editorial), 4
Drug smuggling, whole body irrigation for, 147 bleeding, 303 vascular endothelial growth factor expression
Duodenoscopes, for pediatric patients (editorial), Enteral nutrition, percutaneous endoscopic and tumor angiogenesis in, 28
102 gastrostomy in, 368 Gastric emptying time, B,, vitamin impact on,
Duodenum Enzyme replacement therapy, for Gaucher 230
biopsy of in pediatric upper intestinal disease, 234 Gastric metastasis, percutaneous endoscopic
endoscopy, 39 Eradication therapy, '*C-urea breath test and gastrostomy associated, 307
cancer of, endoscopic or surgical resection referral in, 142 Gastroduodenal disorders, Rome II criteria for
for (editorial), 356 Erratum: “The usefulness of capsulated '*C-urea (letter), 92
early primary nonampullary carcinoma of, breath test in diagnosis of Helicobacter Gastroduodenal ulcer, open versus laparoscopic
clinicopathologic features and endoscopic pylori infection in patients with upper techniques for management of, 226
resection of, 381 gastrointestinal bleeding,” 2003;37:34-38, Gastroesophageal reflux disease (GERD)
Dyspepsia score, with B,, vitamin treatment of 198 24-hour ambulatory esophageal pH
Helicobacter pylori, 230 Esophageal function testing, multichannel monitoring in, 14
Dyspnea, in GERD associated with intraluminal impedance in, 206 acid and non-acid, 206
paraesophageal hiatal hernia, 129 Esophagitis, Celecoxib-associated, 61 pantoprazole improving quality of life with,
Esophagus 132
E malignant melanoma of, heavy-ion respiratory complications of, 129
radiotherapy for, 151 Gastroesophageal reflux monitoring,
Editorials
pH monitoring of multichannel intraluminal impedance in, 206
ambulatory intraesophageal pH monitoring, 3
in GERD diagnosis, 14 Gastrointestinal bleeding
COX-2 and angiogenesis in gastric cancer, 4
technique and interpretation of, 14 endoscopic management of (letter), 91
to cut or not to cut: that is the question, 355
Estrogen, in Klinefelter syndrome and focal Helicobacter pylori in (editorial), 6
detection of Helicobacter pylori in the setting
nodular hyperplasia, 189 obscure, videocapsule endoscopy for, 303
of acute upper gastrointestinal bleeding, 6
Gastrointestinal tract
duodenal cancer: endoscopic or surgical F malignant tumors of, 372
resection?, 356
p27 protein in cancer of, 23
is laparotomy becoming obsolete?, 201 Familial adenomatous polyposis (FAP) Gaucher disease, amyloidosis and gastric
is silymarin hepatoprotective in alcoholic clinicopathology and endoscopic resection of, bleeding with, 234
liver disease?, 278 381 Genetic-based studies, of probiotics and
leflunomide in Crohn’s disease—the cyclooxygenase inhibitors in, 281 prebiotics, 105
open-label case series and the Texas Fatty liver disease, nonalcoholic, with insulin Genetic mutations, in idiopathic acute
sharpshooter, 99 resistance, 399 pancreatitis, 238
pediatric acute pancreatitis—deciphering the Fecal bacteriotherapy, for ulcerative colitis, 42 Genetic testing, in pediatric acute pancreatitis
black box, 100 Fibrin glue, for postpolypectomy hemorrhage (editorial), 100
pediatric ERCP scopes: does size really (letter), 193 Genetics, of inflammatory bowel disease, 358
matter?, 102 Fibrosing colonopathy, in cystic fibrosis Genomics, of probiotics and prebiotics, 105
predicting outcome of critically ill patients Fibrosis Giardia lamblia, routine duodenal biopsy in
with cirrhosis admitted to the intensive alcohol-induced hepatic, silymarin retarding diagnosing, 39
care unit, 203 progression of, 336 Glucose tolerance, in nonalcoholic fatty liver
renal transplantation in HBsAg+ patients, 9 lipid, lipoprotein, and apolipoprotein serum disease, 399
tumor implantation at PEG exit sites in head levels of in, 177 Gluten-free diet
and neck cancer patients: how much Focal nodular hyperplasia, Klinefelter syndrome assessing histologic recovery after in celiac
evidence is enough?, 280
and, 189 disease, 387
wider horizons for hepatitis, 202 Follow-up study, after gluten-free diet in celiac in celiac disease, 299
Elderly, endoscopic retrograde disease, 387 Goldstein, Franz, biography of, |
cholangiopancreatography in (letter), 348 Foreign body Graft failure, from severe recurrent primary
Emphysema, detection of in inflammatory bowel abdominal examination for (letter), 194 sclerosing cholangitis, 344
disease, 292
in hepatic abscess, colonoscopic
Encephalopathy, hepatic, Helicobacter pylori identification of, 82
and, 164 whole body irrigation for, 147
Endoscopes, for pediatric patients (editorial), 102 Free perforation, due to intestinal lymphoma in H2 breath test, in assessing histologic recovery
Endoscopic gastrostomy, placement of without celiac disease, 299 after gluten-free diet in, 387
skin incision, 368 Functional gastroduodenal disorders, Rome II Hashish, whole body irrigation for smuggling of,
Endoscopic resection criteria for (letter), 92 147
for duodenal cancer (editorial), 356 Fusobacterium necrophorum, in hepatic HBeAg seroconversion, in vaccination for
of nonampullary duodenal carcinoma, 381 abscesses of Lemierre syndrome (letter), 196 hepatitis B virus, 330
Endoscopic retrograde HBsAg+ patients, renal transplantation in
cholangiopancreatography G (editorial), 9
in elderly patients (letter), 348 Heartburn, pantoprazole improving quality of life
small-caliber videoduodenoscope for, 173 Gallbladder with, 132
Endoscopy abnormalities ofi n hepatitis A virus, 79 Heavy-ion radiation, for malignant melanoma of
for corrosive ingestion, 119 evaluation of volume and motility of in esophagus, 151]
421
© 2003 Lippincott Williams & Wilkins
| Clin Gastroenterol ¢ Volume 37, Number 5, November/December 2003
Helicobacter pylori Hepatopulmonary syndrome, severe Intestinal lymphangiectasia, group G
B,, vitamin impact on gastric emptying time polycythemia in clinical presentation of strepotococcal empyema complicating
in, 230 (letter), 89 (letter), 270
'SC-urea breath test and referral in Heroine, whole body irrigation for smuggling of, Intestinal perforation
eradication therapy for, 142 147 due to intestinal lymphoma in celiac disease,
'SC-urea breath test in diagnosis of, 34 Hiatal hernia, paraesophageal, respiratory 299
hepatic encephalopathy and, 164 complications of GERD associated with, 129 with transanal decompression intubation
novel ‘°C-urea breath test device in diagnosis Hiccups, intractable, in systemic disease (letter), (letter), 195
of, 139 272 Intestinal permeability, in colorectal cancer,
in the setting of acute upper gastrointestinal Hispanic population, malignant tumors of small raltitrexed and irinotecan treatment and
intestine in, 372 (letter), 192
bleeding (editorial), 6
Histamine 2 receptor antagonist, improving Intraductal papillary mucinous tumor, in
Hematochezia, argon plasma coagulation of, 392
quality of life in heartburn patients, 132 idiopathic acute pancreatitis, 238
Hemochromatosis, in hepatitis C virus, 406
Histologic recovery, assessment of after Intraepithelial lymphocytes, routine duodenal
Hemorrhage
gluten-free diet, 387 biopsy in evaluating, 39
with Gaucher disease, 234
Histology, hepatic iron concentration and in Irinotecan, intestinal permeability in colorectal
postpolypectomy, fibrin glue for (letter), 193
chronic hepatitis C, 406 cancer treatment with (letter), 192
small intestinal, videocapsule endoscopy for,
Hypersensitivity pneumonitis, detection of in Iron deficiency, in malignant tumors of small
303 inflammatory bowel disease, 292 intestine, 372
Hemorrhagic solitary rectal ulcer syndrome,
Hypothyroidism, in non-alcoholic steatohepatitis Iron index, hepatic, in hepatitis C virus, 406
argon plasma coagulation of, 392 risk, 340 Irritable bowel syndrome, probiotics in (letter), 93
Hepatic abscess
colonoscopic identification of foreign body
K
in, 82
Fusobacterium necrophorum in (letter), 196 IgG antibodies, to Helicobacter pylori, 34 Klinefelter syndrome, focal nodular hyperplasia
Hepatic encephalopathy, Helicobacter pylori Immune tolerance, in chronic hepatitis B virus, and, 189
and, 164 330
Hepatic epithelioid hemangioendothelioma, Immunocompetent population, colorectal L
living donor liver transplantation in (letter), adenoma risk in, 72
349 Immunohistochemistry, of gastric cancer, 28 Lactoferrin antibodies, in liver disease diagnosis,
315
Hepatic hydatid disease, endoscopic stenting for Immunomodulators, leflunomide for patients
postoperative biliary strictures due to, 74 intolerant to, 125 Lamivudine
for chemotherapy-induced reactivation of
Hepatic iron concentration, histologic Immunosuppression, in recurrent hepatitis C
hepatitis B virus, 68
progression and in chronic hepatitis C, 406 after liver transplant, 155
good outcome of in chronic renal failure and
Hepatitis Immunotherapy, specific, for hepatitis B virus,
acute viral, cholecystitis due to, 79 330 hepatitis B virus infection, 64
in renal transplantation (editorial), 9
autoimmune Impedance testing, multichannel, in esophageal
Laparoscopic repair, versus open techniques for
diagnosis and management of, 315 function testing and gastroesophageal reflux
perforated gastroduodenal ulcer management,
hepatocellular carcinoma with (letter), monitoring, 206
226
271 Incision-less techniques, as alternatives to
Laparotomy, obsolescence of (editorial), 201
recurrent idiopathic, 267 percutaneous gastrostomy (editorial), 355
Leflunomide
relapsing episodes of (editorial), 202 Infectious disease, with treatment of Crohn’s
for Crohn’s disease, 125
with Salmonella paratyphia A and hepatitis E disease and ulcerative colitis, 220 for Crohn’s disease (editorial), 99
virus coinfection (letter), 350 Inflammatory bowel disease Lemierre syndrome, Fusobacterium
with treatment of Crohn’s disease and fecal bacteriotherapy for, 42
necrophorum hepatic abscesses in (letter),
ulcerative colitis, 220 genetics of, 358
196
Hepatitis A virus, acute viral cholecystitis due to, leflunomide for, 125 Letters to editor
79 natural history and clinical behavior of, 216 acute hepatitis B and isolated
Hepatitis B virus pulmonary function tests and high-resolution thrombocytopenia, 87
good outcome of lamivudine treatment in, 64 CT in detecting pulmonary involvement acute hepatitis with Salmonella paratyphi A
isolated thrombocytopenia and (letter), 87 in, 292 and hepatitis E virus coinfection, 350
pre-S2/S vaccine for, 330 short- and long-term toxicity of are probiotics useful in irritable bowel
prophylaxis against chemotherapy-induced 6-mercaptopurine in treatment of, 220 syndrome?, 93
reactivation of, 68 Insulin resistance, in nonalcoholic fatty liver chronic alcohol intake and gastric
renal transplantation in (editorial), 9 disease, 399 bicarbonate, 86
Hepatitis C virus Intensive care unit endoscopic management of bleeding from
histologic progression and hepatic iron organ system failure scoring system in colonic Dieulafoy-like lesion, 91
concentration in, 406 predicting mortality in, 251 endoscopic retrograde
recurring after liver transplant, 155 predicting outcome of cirrhosis in critically cholangiopancreatography in patients 90
treatment considerations of with cirrhosis, ill patients in (editorial), 203 years of age and older: increasing
395 Interferon experience on its effectiveness and safety,
Hepatitis E virus, Salmonella paratyphia A for hepatitis C with cirrhosis, 395 348
coinfection with (letter), 350 for recurrent hepatitis C after liver transplant, fibrin glue for postpolypectomy hemorrhage,
Hepatocellular carcinoma 155 193
with autoimmune hepatitis (letter), 271 Interleukin-6, in severe acute pancreatitis, 263 group G streptococcal empyema
in nonalcoholic steatohepatitis (letter), 88 Interleukin-8, in severe acute pancreatitis, 263 complicating primary intestinal
transradial approach for transcatheter arterial Intestinal flora lymphangiectasia, 270
chemoembolization in, 412 in irritable bowel syndrome (letter), 93 hepatic abscesses caused by Fusobacterium
Hepatoprotection, in alcoholic liver disease probiotics and prebiotics and, 105 necrophorum as part of the Lemierre
(editorial), 278 in ulcerative colitis treatment, 42 syndrome, 196
422
© 2003 Lippincott Williams & Wilkins
J Clin Gastroenterol « Volume 37, Number 5, November/December 2003
hepatocellular carcinoma associated with M Outcome prediction
autoimmune hepatitis, 271 Malignant tumors, of small intestine, 372 of cirrhosis in critically ill patients (editorial),
intestinal permeability in colorectal cancer Meckel’s diverticulum, video capsule entrapped 203
patients treated by raltitrexed or in (letter), 270 organ system failure scoring system in, 251
irinotecan, 192 Meetings Oxidative stress, in alcohol-induced hepatic
intractable hiccups: a serious sign of international, 98, 200 fibrosis, 336
underlying systemic disease, 272
in United States, 97, 199
is hepatocellular carcinoma part of the Melanoma, malignant, of esophagus, heavy-ion P
natural history of nonalcoholic
steatohepatitis?, 88 radiotherapy for, 151 p27 protein
is liver disease an octreotide side effect?, 86 6-Mercaptopurine in gastrointestinal and liver cancer, 23
living donor liver transplantation in a patient leflunomide for patients intolerant to, 125 in poor prognosis of colorectal cancer in
with hepatic epithelioid short- and long-term toxicity of, 220 elderly patients, 48
hemangioendothelioma, 349 Metastasis, gastric, percutaneous endoscopic p53 protein, in poor prognosis of colorectal
gastrostomy associated, 307
perforation caused by a transanal cancer in elderly patients, 48
decompression tube in large bowel Methtoot, re1x2a5t e, leflunomide for patients intolerant Pancreas, sporadic hereditary desmoid tumor of,
obstruction, 195 186
pheochromocytoma complicated with Micro2l3i8t hiasis, in idiopathic acute pancreatitis, Pancreas divisum, in idiopathic acute
refractory paralytic ileus dramatically pancreatitis, 238
improved with intravenous administration Molecular immune response, probiotics and Pancreatic disease, severe colonic complications
of alpha-adrenergic receptor antagonist, prebiotics in, 105 of, 258
phentolamine, 194 Monoclonal gammopathy, in Gaucher disease, Pancreaticobiliary duct, anomalous union of, in
razor blade “ingestion”—behind the film, 234 idiopathic acute pancreatitis, 238
194 Mortality rate, organ system failure scoring Pancreaticobiliary endoscopy, in pediatric
the Rome II criteria for patients with system in predicting, 251 patients (editorial), 102
functional gastroduodenal disorders, 92 mRNA expression, in poor prognosis of Pancreatitis
severe polycythemia as the first clinics] colorectal cancer in elderly patients, 48 in childhood, 169
presentation of hepatopulmonary Multichannel intraluminal impedance, in colonic complications of, 258
syndrome, 89 esophageal function testing and etiologies of, 238
video capsule entrapped in a Meckel’s gastroesophageal reflux monitoring, 206 fulminant necrotizing, 258
diverticulum, 270 Multisystem organ failure, with necrotizing idiopathic acute, 238
Leukopenia, with treatment of Crohn’s disease pancreatitis, 258 pediatric acute (editorial), 100
and ulcerative colitis, 220 severe acute, early and reliable predictors of,
Linkage analysis, for inflammatory bowel N 263
disease, 358 Natural history with treatment of Crohn’s disease and
Lipids, serum, in nonalcoholic steatohepatitis, of Crohn’s disease, 216 ulcerative colitis, 220
177 in hepatitis C virus, 406 Pantoprazole, improving health-related quality of
Lipoproteins, serum, in nonalcoholic life with heartburn patients, 132
Neoplasms
steatohepatitis, 177 Paralytic ileus, refractory, with
malignant, of small intestine, 372
Liver pheochromocytoma (letter), 194
with treatment of Crohn’s disease and
biopsy of in relapsing hepatitis episodes Patient referral pattern, in Helicobacter pylori
ulcerative colitis, 220
(editorial), 202 eradication therapy, 142
Nissen fundoplicature, for GERD associated with
cancer of, p27 protein in, 23 Pegylated interferon, for hepatitis C with
paraesophageal hiatal hernia, 129
cirrhosis of Nizatidine, improving quality of life in heartburn cirrhosis, 395
Helicobacter pylori and, 164 Peptic ulcers, laparotomy for (editorial), 201
patients, 132
organ system failure scoring system in Percutaneous gastrostomy
Nonalcoholic fatty liver disease, with insulin
predicting mortality with, 251 resistance, 399 complications of (editorial), 355
Liver disease endoscopic
Nonsteroidal anti-inflammatory drugs (NSAIDs),
alcoholic, silymarin in (editorial), 278 in colorectal adenomas and cancer, 281 in gastric metastasis, 307
autoantibodies in diagnosis and management placement of without skin incision, 368
of, 315 O tumor implantation, at exit sites of
Klinefelter syndrome and, 189 (editorial), 280
octreotide in (letter), 86 Occult blood, in malignant tumors of small Perforated gastroduodenal ulcer, open versus
recurrent after orthotopic liver intestine, 372 laparoscopic techniques for management of,
transplantation, 344 Octreotide, in liver disease (letter), 86 226
Liver re-transplantation, for hepatitis C virus, Oddi, sphincter of, dysfunction of, in idiopathic Perinuclear anti-neutrophil cytoplasmic
155 acute pancreatitis, 238 antibodies, in liver disease diagnosis and
Liver transplant recipients, colorectal adenoma On-line breath test, for Helicobacter pylori management, 315
risk in, 72 diagnosis, 139 pH monitoring
Liver transplantation Open-label case series, in Crohn’s disease ambulatory 24-hour esophageal, 14
living donor, with hepatic epithelioid (editorial), 99 ambulatory intraesophageal (editorial), 3
hemangioendothelioma (letter), 349 Open surgical techniques, for perforated multichannel impedance testing in, 206
orthotopic, graft failure from recurrent gastroduodenal ulcer management, 226 Phentolamine, for pheochromocytoma
sclerosing cholangitis following, 344 Oral glucose tolerance test, for nonalcoholic fatty complicated with refractory paralytic ileus
recurrent hepatitis C after, 155 liver disease, 399 (letter), 194
Lye ingestion, in adults, 119 Organ System Failure (OSF) classification Pheochromocytoma, refractory paralytic ileus
Lymphoma in predicting outcome of cirrhosis in with (letter), 194
intestinal, free perforation due to, 299 critically ill patients (editorial), 203 Plasma ammonia, in hepatic encephalopathy, 164
with treatment of Crohn’s disease and scoring system of in predicting hospital Polycythemia, in hepatopulmonary syndrome
ulcerative colitis, 220 mortality in cirrhosis, 251 presentation (letter), 89
© 2003 Lippincott Williams & Wilkins 423
| Clin Gastroenterol ¢ Volume 37, Number 5, November/December 2003
Polypectomy, fibrin glue for hemorrhage after Rome II criteria, for functional gastroduodenal Transradial approach, for chemoemoblization for
(letter), 193 disorders (letter), 92 hepatocellular carcinoma, 412
Prebiotics, new scientific paradigms for, 105 Roth, Bennett E., biography of, 275 Trypsinogen, cationic, in idiopathic acute
Probiotics pancreatitis, 238
Ss
in irritable bowel syndrome (letter), 93 Tumor necrosis factor, in severe acute
new scientific paradigms for, 105 Salmonella paratyphia A, acute hepatitis with pancreatitis, 263
for ulcerative colitis, 42 (letter), 350 Tumor suppressor genes, down-regulation of, in
Prognosis Sclerosing cholangitis, recurrent primary, graft poor prognosis of colorectal cancer, 48
of colorectal cancer in elderly, 48 failure from, 344 Tumors
organ system failure scoring system in, 251 Sepsis-Related Organ Failure Assessment angiogenesis of in gastric cancer, 28
Prognostic markers, in gastrointestinal and liver (SOFA), in predicting outcome of cirrhosis in duodenal, endoscopic or surgical resection
for (editorial), 356
cancers, 23 critically ill patients (editorial), 203 in idiopathic acute pancreatitis, 238
Prostaglandins, in colorectal adenomas and Serum, lipid, lipoprotein, and apolipoprotein
cancer, 281 levels ofi n nonalcoholic steatohepatitis, 177 implantation ofa t PEG exit sites in head and
Proton pump inhibitors, improving quality of life Sex hormones, in Klinefelter syndrome and focal neck cancer (editorial), 280
in heartburn patients, 132 nodular hyperplasia, 189 malignant, of small intestine, 372
Puerto Rico, malignant tumors of small intestine Siderosis, in hepatitis C virus, 406 sporadic hereditary pancreatic desmoid, 186
in, 372 Silymarin U
Pulmonary abnormalities, detection of in in hepatoprotection (editorial), 278
inflammatory bowel disease, 292 retarding alcohol-induced hepatic fibrosis Ulcerative colitis
Pulmonary disorders, in GERD associated with progression, 336 fecal bacteriotherapy for, 42
paraesophageal hiatal hernia, 129 Sjogren’s syndrome, with Crohn’s disease, 312 genetics of, 358
Pulmonary function tests, for pulmonary Skin incision, in percutaneous endoscopic short- and long-term toxicity of
involvement in inflammatory bowel disease, gastrostomy, 368 6-mercaptopurine in treatment of, 220
292 Small intestine, malignant tumors of, 372 Ultrasonography
Pyrimidine analog, for Crohn’s disease Smooth muscle antibodies, in liver disease of bowel wall thickness in cystic fibrosis, 55
(editorial), 99 diagnosis and management, 315 real-time, in evaluation of gallbladder
Sodium hydroxide, ingestion of, 119 volume and motility of in
Solitary ulcer syndrome, hemorrhagic rectal, 392 non-insulin-dependent diabetes mellitus,
Q Sorbitol, in histologic recovery after gluten-free 288
diet in, 387 Upper gastrointestinal bleeding
Quality of life, health-related, pantoprazole and, Steatohepatitis 'SC-urea breath test in diagnosing, 34
132 lipid, lipoprotein, and apolipoprotein serum Helicobacter pylori in (editorial), 6
leveolfs i n, 177 Urogenital immunity, probiotics and prebiotics
R nonalcoholic in, 105
hepatocellular carcinoma and (letter), 88 Ursodeoxycholic acid, in weight gain in biliary
Radiotherapy, heavy-ion, for malignant hypothyroidism as risk factor for, 340 cirrhosis patients, 183
melanoma of esophagus, 151 Streptococcal empyema, group G, complicating
V
Ralitrexed, intestinal permeability in colorectal primary intestinal lymphangiectasia (letter),
cancer treatment with (letter), 192 270 Vaccination, for hepatitis B virus, 330
Razor blade ingestion, abdominal examination Surgical resection, for duodenal cancer Vascular ectasia, videocapsule endoscopy for,
for (letter), 194 (editorial), 356 303
Rectal pain, in hemorrhagic solitary rectal ulcer Surgical techniques Vascular endothelial growth factor (VEGF)
syndrome, 392 laparoscopic (editorial), 201 in gastric cancer, 28
Reflux monitoring, ambulatory intraesophageal for perforated gastroduodenal ulcer in gastric cancer (editorial), 4
(editorial), 3 management, 226 Videocapsule, entrapped in Meckel’s
Renal failure, chronic, good outcome of Symbiotics, definition and guidelines for, 105 diverticulum (letter), 270
lamivudine treatment in, 64 Systemic disease, intractable hiccups in (letter), Videocapsule endoscopy, for obscure
Renal transplantation, in HBsAg+ patients 979 gastrointestinal bleeding, 303
(editorial), 9 T Videoduodenoscopes, small-caliber, 173
Respiratory disorders, with GERD-associated Vienna classification, of Crohn’s disease, 216
paraesophageal hiatal hernia, 129 T-cell lymphoma, free perforation due to, 299 Viral load, in recurrent hepatitis C after liver
Respiratory failure, acute, in GERD associated Thrombocytopenia, acute hepatitis B and (letter), transplant, 155
with paraesophageal hiatal hernia, 129 87
W
Ribavirin Thyroid hormone replacement, in non-alcoholic
for hepatitis C with cirrhosis, 395 steatohepatitis, 340 Weight gain, in biliary cirrhosis patients, 183
for recurrent hepatitis C after liver transplant, Transanal decompression tube, perforation Whole body irrigation, for contraband
155
caused by (letter), 195 bodypackers, 147
2003 Lippincott Williams & Wilkins